Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1152 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Axicabtagene ciloleucel for relapsed/refractory diffuse large B-cell lymphoma – second-line	Axicabtagene Ciloleucel (Yescarta; KTE-C19)	Diffuse large B-cell lymphoma (DLBCL)	Haematological Cancer and Lymphomas	2019	View \| Download
Axicabtagene ciloleucel for relapsed/refractory indolent non-Hodgkin lymphoma	Axicabtagene Ciloleucel (Yescarta; KTE-C19)	Non-Hodgkin lymphoma (NHL)	Haematological Cancer and Lymphomas	2019	View \| Download
Axicabtagene ciloleucel IV for relapsed/refractory acute lymphoblastic leukaemia in children and adolecents (aged 2-21 years) – second line	Brexucabtagene autoleucel (Tecartus; KTE-X19)	Acute lymphoblastic leukaemia (ALL)	Haematological Cancer and Lymphomas	2017	View \| Download
Axitinib for Patients at High Risk of Recurrence of Renal Cell Carcinoma – Adjuvant	Axitinib (Inlyta; AG-013736)	Renal cell carcinoma (RCC)	Renal Cancer	2018	View \| Download
AZD3152 for preventing COVID-19	AZD3152	COVID-19	Infectious Disease	2023	View \| Download
Baloxavir marboxil for the post-exposure prevention of influenza in people aged 12 years and older	Baloxavir marboxil (Xofluza; S-033188)	Influenza	Infectious Disease	2020	View \| Download
Baloxavir marboxil for the treatment of influenza in patients aged 12 years and older and are at high risk of developing influenza complications	Baloxavir marboxil (Xofluza; S-033188)	Influenza	Infectious Disease	2020	View \| Download
Baloxavir marboxil for treating paediatric patients 1 to <12 years of age with influenza	Baloxavir marboxil (Xofluza; S-033188)	Influenza	Infectious Disease	2021	View \| Download
Baloxavir marboxil for treatment of influenza A or B infection in otherwise healthy patients aged 12 years and older	Baloxavir marboxil (Xofluza; S-033188)	Influenza	Infectious Disease	2018	View \| Download
Bardoxolone Methyl for the treatment of chronic kidney disease (CKD) caused by Alport Syndrome	Bardoxolone Methyl	Alport Syndrome , Chronic kidney disease (CKD)	Genetic Disorders , Nephrology	2022	View \| Download